CN103083461A - Medicine composition for treating diabetes - Google Patents
Medicine composition for treating diabetes Download PDFInfo
- Publication number
- CN103083461A CN103083461A CN2012105179432A CN201210517943A CN103083461A CN 103083461 A CN103083461 A CN 103083461A CN 2012105179432 A CN2012105179432 A CN 2012105179432A CN 201210517943 A CN201210517943 A CN 201210517943A CN 103083461 A CN103083461 A CN 103083461A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- raw material
- mentioned
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine composition for treating diabetes. A first traditional Chinese medicine raw material group of the medicine composition comprises 98 parts-102 parts of atractylis ovata, 148 parts-152 parts of scrophularia ningpoensis, 98 parts-102 parts of radix rehmanniae, 48 parts -52 parts of pyrolusite, and 98 parts-102 parts of rhizoma coptidis. The medicine composition for treating diabetes, which is developed according to the muslin medicine theory and characters of muslin medicine and takes the atractylis ovata, the scrophularia ningpoensis, the radix rehmanniae, the pyrolusite (muslin medicine) and rhizoma coptidis as raw materials, gives full play to the pharmaceutical effect of synergistic treatment, good effect of nourishing yin to lessen fire and promoting the production of body fluid to quench thirst by matching the traditional Chinese medicine raw materials in the parts by weight and further eliminates the symptoms of polydipsia with desire for drinking, mouth parched and tongue scorched and thinnest in bodily form of patients.
Description
Technical field:
The present invention relates to medical technical field, particularly a kind of Chinese medicine composition for the treatment of diabetes.
Background technology:
Diabetic foot is the endocrine and metabolic disorders disease that is caused by inherited genetic factors and the long-term combined effect of environmental factors, is classified as one of " three is large " killer of the mankind by the World Health Organization (WHO).
Treatment for diabetes, Traditional Chinese Medicine is discussed mainly with " three types of diabetes " and is controlled, (dryness of the lung) polydipsia disappears namely, in (gastric heat) polyphagia that disappears, under (suffering from a deficiency of the kidney) polyuria that disappears, think that its pathogenesis is that the deficiency of YIN is scorching, thus with replenishing YIN and removing heat as Therapeutic Method, facts have proved that this method has been unsuitable for the dialectical treatment of diabetes; Although the present age, some doctors adopted some new medicine typing methods in the treatment of diabetes, but take a broad view of its Therapeutic Method, still take replenishing YIN and removing heat as main, add simultaneously with method for the treatment of such as supplementing QI for promoting the production of body fluid, blood circulation promoting and blood stasis dispelling, activating QI to eliminate phlegm, the kidney warming the kidney invigorating, its essence does not have large development and variation; Modern doctor trained in Western medicine thinks that the key of diabetes is the islet function obstacle.Or hypoinsulinism, or the Insulin receptor INSR combination rate is low, causes the sugar of taking in human body that body is taken full advantage of, and accumulates in to occur hyperglycemia in blood.
Traditional Chinese Medicine treatment diabetes lay special stress on organic conception, determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs, regulating yin and yang, the viewpoint of too many levels conditioning, this and modern medicine have similarity to the treating diabetes viewpoint, demonstrate Chinese medicine and aspect treating diabetes, some superiority is arranged, and Chinese medicine is cheap, toxic and side effects is little, little on the organ impact, worth Devoting Major Efforts To Developing is promoted the use of, though there were in recent years some Chinese medicines to be used for the treatment of diabetes, the effect of TCM treatment of diabetes is not outstanding for many years, the clinical experiment effect is not remarkable yet, treatment means is also more single, so also fail to obtain good result.In order to solve this difficult problem, people are constantly exploring and are studying, and however, the therapeutic effect of existing Chinese medicine preparation still can not be satisfactory.
Summary of the invention:
In view of this, be necessary to provide a kind of therapeutic effect to treat significantly the Chinese medicine composition of diabetes.
A kind of Chinese medicine composition for the treatment of diabetes comprises the first raw material of Chinese medicine group of following parts by weight: 98 parts ~ 102 parts of Rhizoma Atractylodis, 148 parts ~ 152 parts of Radix Scrophulariaes, 98 parts ~ 102 parts, the Radix Rehmanniae, 48 parts ~ 52 parts of pyrolusitums, 98 parts ~ 102 parts of Rhizoma Coptidis.
The inventor reaches back according to returning theory of medicine the Chinese medicine composition that the medicine characteristic is developed above-mentioned treatment diabetes, with Rhizoma Atractylodis, Radix Scrophulariae, the Radix Rehmanniae, pyrolusitum (returning medicine), Rhizoma Coptidis as raw material of Chinese medicine, simultaneously above-mentioned raw material of Chinese medicine is given full play of the drug effect of Synergistic treatment according to above-mentioned parts by weight proportioning, give full play of nourishing YIN to lower pathogenic fire, promoting the production of body fluid to quench thirst effect, and then solve the symptom that excessive thirst polydipsia, dry mouth and tougue, frequent micturition frequent micturition, the bodily form of diabetics are become thin.
Description of drawings:
The specific embodiment:
The inventor is according to returning theory of medicine and returning the Chinese medicine composition that the medicine characteristic is developed following treatment diabetes.
The Chinese medicine composition of these treatment diabetes comprises the first raw material of Chinese medicine group of following parts by weight: 98 parts ~ 102 parts of Rhizoma Atractylodis, 148 parts ~ 152 parts of Radix Scrophulariaes, 98 parts ~ 102 parts, the Radix Rehmanniae, 48 parts ~ 52 parts of pyrolusitums (return the medicine name: manna is also received), 98 parts ~ 102 parts of Rhizoma Coptidis.
For the Chinese medicine composition that makes above-mentioned treatment diabetes can fully reach the most effective therapeutic effect, the Chinese medicine composition of above-mentioned treatment diabetes also further comprises the second raw material of Chinese medicine group of following parts by weight: 98 parts ~ 102 parts of Radix Solani Melongenae, 98 parts ~ 102 parts of Bombyx bombycis; Wherein, the first raw material of Chinese medicine group is ground, the cake ball, the large piller of Semen phaseoli radiati processed is for for oral administration; Fry in shallow oil soup after the second raw material of Chinese medicine group is added suitable quantity of water, obtained to close with the first raw material of Chinese medicine assembly the oral liquid of taking.Above-mentioned umber can represent with g.
The concrete gravimetric value (wherein, every part is 1g) of raw material of Chinese medicine of the Chinese medicine composition of above-mentioned treatment diabetes is below described for example:
In one: the first raw material of Chinese medicine group of filling a prescription: Rhizoma Atractylodis 98 g, Radix Scrophulariae 148 g, the Radix Rehmanniae 98 g, pyrolusitum 48 g, Rhizoma Coptidis 98 g; In the second raw material of Chinese medicine group: Radix Solani Melongenae 98 g, Bombyx bombycis 98 g.
In two: the first raw material of Chinese medicine groups of filling a prescription: Rhizoma Atractylodis 100 g, Radix Scrophulariae 150 g, the Radix Rehmanniae 100 g, pyrolusitum 50 g, Rhizoma Coptidis 100 g; In the second raw material of Chinese medicine group: Radix Solani Melongenae 100 g, Bombyx bombycis 100 g.
In three: the first raw material of Chinese medicine groups of filling a prescription: Rhizoma Atractylodis 102 g, Radix Scrophulariae 152 g, the Radix Rehmanniae 102 g, pyrolusitum 52 g, Rhizoma Coptidis 102 g; In the second raw material of Chinese medicine group: Radix Solani Melongenae 102 g, Bombyx bombycis 102 g.
Below the Chinese medicine composition clinical application effect explanation of above-mentioned treatment diabetes:
patient man 51 years old, in in JIUYUE, 2010 with polydipsia, polyuria, polyphagia, diagnosed type 2 diabetic on inspection, take metformin invalid, come my institute to see a doctor, thirsty polydipsia, vexed uneasiness, the polyphagia polyphagia, the urine amount is many, be hard and dry, full and large pulse, red tongue, the few Tianjin of yellow fur, check fasting glucose 14.2mmol/L, glucose in urine (++ ++), card belongs to exuberant lung-stomach heat, body fluid being damaged, control suitable clearing heat and moistening dryness, promoting the production of body fluid and benefiting QI, give holy Jinsui River ball that helps, serve on 15 doses, thirsty polyphagia, much the subtracting of urine amount, stool is normal, tongue arteries and veins normal, check fasting glucose 9.4mmol/L, glucose in urine (++), continue to take 15 doses, subjective symptoms disappears, fasting glucose 5.9mmol/L, glucose in urine (-).
Sum up; The inventor reaches back according to returning theory of medicine the Chinese medicine composition that the medicine characteristic is developed above-mentioned treatment diabetes, with Rhizoma Atractylodis, Radix Scrophulariae, the Radix Rehmanniae, pyrolusitum (returning medicine), Rhizoma Coptidis as raw material of Chinese medicine, simultaneously above-mentioned raw material of Chinese medicine is given full play of the drug effect of Synergistic treatment according to above-mentioned parts by weight proportioning, give full play of nourishing YIN to lower pathogenic fire, promoting the production of body fluid to quench thirst effect, and then solve the symptom that excessive thirst polydipsia, dry mouth and tougue, frequent micturition frequent micturition, the bodily form of diabetics are become thin.
Claims (5)
1. a Chinese medicine composition for the treatment of diabetes, is characterized in that: the first raw material of Chinese medicine group that comprises following parts by weight: 98 parts ~ 102 parts of Rhizoma Atractylodis, 148 parts ~ 152 parts of Radix Scrophulariaes, 98 parts ~ 102 parts, the Radix Rehmanniae, 48 parts ~ 52 parts of pyrolusitums, 98 parts ~ 102 parts of Rhizoma Coptidis.
2. the Chinese medicine composition for the treatment of diabetes according to claim 1, it is characterized in that: the Chinese medicine composition of above-mentioned treatment diabetes also comprises the second raw material of Chinese medicine group of following parts by weight: 98 parts ~ 102 parts of Radix Solani Melongenae, 98 parts ~ 102 parts of Bombyx bombycis; Wherein, the first raw material of Chinese medicine group is ground, the cake ball, the large piller of Semen phaseoli radiati processed is for for oral administration; Fry in shallow oil soup after the second raw material of Chinese medicine group is added suitable quantity of water, obtained to close with the first raw material of Chinese medicine assembly the oral liquid of taking.
3. the Chinese medicine composition for the treatment of diabetes according to claim 1, it is characterized in that: the every umber of above-mentioned raw material of Chinese medicine represents with 1g, and above-mentioned the first raw material of Chinese medicine is specially: Rhizoma Atractylodis 98 g, Radix Scrophulariae 148 g, the Radix Rehmanniae 98 g, pyrolusitum 48 g, Rhizoma Coptidis 98 g; In above-mentioned the second raw material of Chinese medicine group: Radix Solani Melongenae 98 g, Bombyx bombycis 98 g.
4. the Chinese medicine composition for the treatment of diabetes according to claim 1, it is characterized in that: the every umber of above-mentioned raw material of Chinese medicine represents with 1g, and above-mentioned the first raw material of Chinese medicine is specially: Rhizoma Atractylodis 100 g, Radix Scrophulariae 150 g, the Radix Rehmanniae 100 g, pyrolusitum 50 g, Rhizoma Coptidis 100 g; In above-mentioned the second raw material of Chinese medicine group: Radix Solani Melongenae 100 g, Bombyx bombycis 100 g.
5. the Chinese medicine composition for the treatment of diabetes according to claim 1, it is characterized in that: the every umber of above-mentioned raw material of Chinese medicine represents with 1g, and above-mentioned the first raw material of Chinese medicine is specially: Rhizoma Atractylodis 102 g, Radix Scrophulariae 152 g, the Radix Rehmanniae 102 g, pyrolusitum 52 g, Rhizoma Coptidis 102 g; In above-mentioned the second raw material of Chinese medicine group: Radix Solani Melongenae 102 g, Bombyx bombycis 102 g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012105179432A CN103083461A (en) | 2012-12-06 | 2012-12-06 | Medicine composition for treating diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012105179432A CN103083461A (en) | 2012-12-06 | 2012-12-06 | Medicine composition for treating diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103083461A true CN103083461A (en) | 2013-05-08 |
Family
ID=48196940
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012105179432A Pending CN103083461A (en) | 2012-12-06 | 2012-12-06 | Medicine composition for treating diabetes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103083461A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115779046A (en) * | 2022-12-08 | 2023-03-14 | 浙江中医药大学 | Traditional Chinese medicine composition for preventing and treating diabetes, traditional Chinese medicine preparation and application |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010000070A (en) * | 2000-01-11 | 2001-01-05 | 김찬호 | Agents for diabetes and the manufacturing method thereof |
| CN1311017A (en) * | 2001-02-26 | 2001-09-05 | 吕玉娥 | Medicine for curing diabetes |
| US20020197334A1 (en) * | 2001-01-22 | 2002-12-26 | Lee Seung Young | Pharmaceutical composition for the treatment of diabetes mellitus |
| US20050019435A1 (en) * | 2003-07-21 | 2005-01-27 | Jeffrey Young | Method of treating non-insulin dependent diabetes mellitus and related complications |
| CN1943713A (en) * | 2005-10-08 | 2007-04-11 | 周小明 | A Chinese traditional medicinal composition for treating diabetes and its preparation method |
| CN101120984A (en) * | 2006-08-08 | 2008-02-13 | 芮育健 | New use of traditional Chinese medicines radix astragali, rehmanniae radix and scutellaria for heat-clearing antitoxic and treating diabetes |
| KR100927435B1 (en) * | 2008-05-21 | 2009-11-19 | 조신영 | Pill type a healthy food for improving and alleviating the diabetes and preparation method thereof |
| CN102091177A (en) * | 2011-03-16 | 2011-06-15 | 天津工业大学 | Traditional Chinese medicine health product for adjuvant therapy of diabetes |
| CN102526332A (en) * | 2012-02-07 | 2012-07-04 | 广西圣特药业有限公司 | Medicine for treating diabetes and preparation method thereof |
-
2012
- 2012-12-06 CN CN2012105179432A patent/CN103083461A/en active Pending
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010000070A (en) * | 2000-01-11 | 2001-01-05 | 김찬호 | Agents for diabetes and the manufacturing method thereof |
| US20020197334A1 (en) * | 2001-01-22 | 2002-12-26 | Lee Seung Young | Pharmaceutical composition for the treatment of diabetes mellitus |
| CN1311017A (en) * | 2001-02-26 | 2001-09-05 | 吕玉娥 | Medicine for curing diabetes |
| US20050019435A1 (en) * | 2003-07-21 | 2005-01-27 | Jeffrey Young | Method of treating non-insulin dependent diabetes mellitus and related complications |
| CN1943713A (en) * | 2005-10-08 | 2007-04-11 | 周小明 | A Chinese traditional medicinal composition for treating diabetes and its preparation method |
| CN101120984A (en) * | 2006-08-08 | 2008-02-13 | 芮育健 | New use of traditional Chinese medicines radix astragali, rehmanniae radix and scutellaria for heat-clearing antitoxic and treating diabetes |
| KR100927435B1 (en) * | 2008-05-21 | 2009-11-19 | 조신영 | Pill type a healthy food for improving and alleviating the diabetes and preparation method thereof |
| CN102091177A (en) * | 2011-03-16 | 2011-06-15 | 天津工业大学 | Traditional Chinese medicine health product for adjuvant therapy of diabetes |
| CN102526332A (en) * | 2012-02-07 | 2012-07-04 | 广西圣特药业有限公司 | Medicine for treating diabetes and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 洪文旭: "《天然药物四百味》", 30 September 2010, article "无名异", pages: 451 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115779046A (en) * | 2022-12-08 | 2023-03-14 | 浙江中医药大学 | Traditional Chinese medicine composition for preventing and treating diabetes, traditional Chinese medicine preparation and application |
| CN115779046B (en) * | 2022-12-08 | 2024-05-03 | 浙江中医药大学 | Traditional Chinese medicine composition, traditional Chinese medicine preparation and application for preventing and treating diabetes |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103463417B (en) | Traditional Chinese medicine used for treating irritable bowel syndrome | |
| CN100509025C (en) | A medicine for treating diabetes | |
| CN103083461A (en) | Medicine composition for treating diabetes | |
| CN103800689A (en) | Traditional Chinese medicine composition for treating diabetes mellitus | |
| CN116270872A (en) | Traditional Chinese medicine composition for treating chronic kidney disease | |
| CN101095881B (en) | Decoction medicine for treating food retention type biliary ascariasis and preparation method thereof | |
| CN101195003B (en) | Proprietary Chinese medicine for treating apoplexy and sequela | |
| CN103169882A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN103463588A (en) | Traditional Chinese medicine composition for treating sinking of qi of middle-jiao | |
| CN102631618A (en) | Traditional Chinese medicine for treating diabetes | |
| CN100998824A (en) | Oral Chinese medicine for treating virus myocarditis | |
| CN103656488B (en) | A kind of Chinese medicine composition for the treatment of diabetes complicated diabetic foot | |
| CN103550660B (en) | A kind of Chinese medicine composition for the treatment of diabetes | |
| CN114588243B (en) | Two alternately taken Chinese medicinal formulas for treating depression and anxiety | |
| CN104687032A (en) | Health caring echinacea health product | |
| CN108524897A (en) | A kind of drug and preparation method thereof for treating type of deficiency of both QI and YIN functional consitipation | |
| CN103028080A (en) | Traditional Chinese medicine decoction for treating qi-stagnancy and blood stasis prostatitis | |
| CN101797351B (en) | Traditional Chinese medicine for preventing senile dementia | |
| CN100998750A (en) | Oral traditional Chinese medicine for treating viral myocarditis of yin deficiency and blood stasis type | |
| CN1305501C (en) | Diabetes treating medicine | |
| CN100998847A (en) | Oral Chinese medicine for treating throat pain type virus myocarditis | |
| CN106237230A (en) | A kind of Chinese medicine formula treating diabetic nephropathy | |
| CN104758889A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN103705631B (en) | Gegenjiangtang capsules and preparation method | |
| CN105477102A (en) | Traditional Chinese medicine for treating type 2 diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130508 |